Pilot Efficacy Study to Treat Gingivitis
Phase II Pilot Efficacy Study to Treat Gingivitis
Sponsor: Biomedical Development Corporation
Listed as NCT00391547, this PHASE2 trial focuses on Gingival Diseases and remains completed. Sponsored by Biomedical Development Corporation, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Oct 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Biomedical Development Corporation
- National Institute of Nursing Research (NINR)
For direct contact, visit the study record on ClinicalTrials.gov .